Molecular diagnostics,
beyond the laboratory.
AscellaOne combines isothermal nucleic acid amplification with a handheld reader, a single-use cartridge and a smartphone app, to bring molecular testing closer to where care happens.
Bringing molecular testing closer to where care happens.
Molecular testing is typically performed in central laboratories, which makes it harder to act on results during the same visit. AscellaOne is a compact platform designed to make nucleic acid testing practical close to the point of care.
Designed with healthcare settings in mind.

Clinics
Primary care and outpatient settings.

Hospital wards
Wards, ICUs and emergency departments.

Long-term care
Care facilities, with testing performed by healthcare professionals.

Field response
Disaster and emergency medical response.
Human diagnostic uses are subject to regulatory clearance in each market.
Grant.
NIH RADx grant (2024)
Ascella Biosystems was awarded a grant under the RADx program of the US National Institutes of Health.
Building the next generation of point-of-care testing, together.
We are seeking development, manufacturing and distribution partners for human IVD and veterinary applications.

